MEDIKINET MR 20 MG MODIFIED-RELEASE CAPSULES

国家: 以色列

语言: 英文

来源: Ministry of Health

有效成分:

METHYLPHENIDATE HYDROCHLORIDE 20 MG

可用日期:

MEDILINE LTD.

ATC代码:

N06BA04

药物剂型:

MODIFIED RELEASE CAPSULES

给药途径:

PER OS

厂商:

MEDICE ARZNEIMITTEL PUETTER GMBH & CO.KG, GERMANY

治疗组:

METHYLPHENIDATE

疗效迹象:

Medikinet Modified Release Capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (ADHD) in children over 6 years of age when remedial measures alone prove insufficient. Treatment must be under the supervision of a specialist in childhood behavioural disorders. Diagnosis should be made according to DSM-IV criteria or the guidelines in ICD-10.

授权日期:

2011-05-01